MR Contrast Agent May Trigger Rare, Fatal Fibrosis

The FDA is asking health care professionals and patients to report possible cases of nephrogenic systemic fibrosis and nephrogenic fibrosing dermopathy through the MedWatch program by phone (800-FDA-1088) or by the Internet at www.fda.gov/medwatch/index.html.